IP Library Granted Patent US 10,870,853
Granted Patent B2
US 10,870,853 · App. 16/148,015 · Granted Dec 22, 2020

Compositions and methods for modulating neuronal excitability and motor behavior

Inventors: Anne Schaefer (New York, NY); Paul Greengard (New York, NY)
Assignees: ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI; THE ROCKEFELLER UNIVERSITY
C12N15/113A01K67/0275A01K67/0276A61K38/185A61K49/0008G01N33/5058A01K2217/052A01K2217/075A01K2217/203A01K2227/105A01K2267/0356A61P25/08C12N2310/141C12N2310/315C12N2310/321C12N2310/341C12N2310/346C12N2310/3515C12N2310/3521
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,870,853
App. No.
16/148,015
Granted
Dec 22, 2020
Kind
B2
Abstract

The invention is directed to compositions and methods for treating or reducing the likelihood of the development of epilepsy in an individual. The method comprises administering to the central nervous system of an individual in need of such treatment a therapeutically effective amount of an agent capable of increasing the expression and/or activity of miR-128.

Claims (11)

1. A method for treating or reducing the likelihood of the development or occurrence of seizures in an individual at risk for or having seizures, wherein said individual has suffered a prior brain injury caused by hypoxia or a prior traumatic brain injury comprising administering to said individual a therapeutically effective amount of a miR-128 having the nucleotide sequence:

(SEQ ID NO: 1)

UCACAGUGAACCGGUCUCUUU.

2. The method of claim 1 , wherein the agent is administered intrathecally or intranasally.

3. The method of claim 1 , wherein the agent is administered to the central nervous system of the individual.

4. The method of claim 1 , wherein the agent is administered to the hippocampus or cortex.

5. The method of claim 1 , wherein the brain injury is caused by is hypoxia.

6. The method of claim 5 , wherein the hypoxia is caused by stroke.

7. The method of claim 5 , wherein the agent is administered intrathecally or intranasally.

8. The method of claim 1 , wherein said individual has suffered a prior traumatic brain injury.

9. The method of claim 8 , wherein the agent is administered intrathecally or intranasally.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 20, 2021
From: TAN, CHAN LEK
To: ROCKEFELLER UNIVERSITY
Reel/Frame 057851/0984 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 4, 2018
From: SCHAEFER, ANNE
To: ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
Reel/Frame 047067/0981 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 3, 2018
From: GREENGARD, PAUL
To: THE ROCKEFELLER UNIVERSITY
Reel/Frame 047052/0047 →
Continuity (4)
Continuation 15032255
Provisional Application 61898952 · Nov 1, 2013
Provisional Application 61896463 · Oct 28, 2013
Related Publication 20190144858A1 · May 16, 2019